Abstract:The Editor, Sir, Rheumatoid arthritis (RA) is a chronic autoimmune disease; deferment and relapse of aggressive synovitis finally leads to destruction of joint cartilage and bone, and that is the main hazard of the disease. In recent years, biologic agents have become a hot spot of RA treatment research, owing to their higher specificity and fewer side effects than existing non-biologic disease-modifying and anti-inflammatory drugs. Although experimentally-induced arthritis models of rhesus monkeys are considered to be the closest model to the human RA disease (1), in the evaluation of preclinical biologic therapeutics, whether the disease also relapses in rhesus monkey models and the correspondent treatment efficacy in that condition were rarely studied. The reason for this phenomenon is that it was considered that induced-arthritis in rhesus monkeys is a monophasic course, and findings in previous studies also seemed to accord with this opinion: most common surrogate markers for the rhesus monkey model, ie clinical scoring, inflammatory and immunological markers, returned to the normal range within a typical follow-up time (70 days) after disease induction (2). However, nowadays, in addition to the aforementioned traditional markers, a more sensitive imaging method, magnetic resonance imaging (MRI) with features of high soft-tissue resolution, multisection and multiparameter, has the unique advantage of being able to visualize the subclinical inflammatory synovium in clinical studies (3). In RA patients in remission according to the 28-joint Disease Activity Score-C-reactive protein (DAS28-CRP), persistent active synovial inflammation detected by MRI is a high-risk predictor of subsequent joint destruction (4). Therefore, high-sensitivity MRI may give a deeper understanding in experimentally-induced arthritis in rhesus monkeys. In our previous study, we used MRI for dynamic evaluation of small hand joints in induced-arthritis models of rhesus monkeys treated with Celebrex (celecoxib). On day 90 after disease induction, MRI still revealed active synovitis in small hand joints in some monkeys (Figure), but common markers (ie clinical scoring and CRP) had returned to normal. Figure Magnetic resonance imaging (MRI) of small hand joints in rhesus monkeys with induced-arthritis. These data suggest that the sensitivity of conventional indicators may be insufficient, leading to a lack of awareness of changes in the disease of rhesus monkey models. The clinical significance of induced-arthritis models of rhesus monkeys to the study of the chronic course of RA may be underestimated. Therefore, sensitive imaging detective method MRI is essential to further preclinical studies. The more accurate method may play a critical role in the evaluation of disease progression and prognosis in induced-arthritis model of rhesus monkeys. This is beneficial not only to help identify proper models that are more consistent with the human RA chronic disease progression, but also to ascertain clinical significance in new biologic agent therapy strategy.

Collagen-induced arthritis in common marmosets: a new nonhuman primate model for chronic arthritis

Resistance to collagen-induced arthritis in a nonhuman primate species maps to the major histocompatibility complex class I region.

Modeling human arthritic diseases in nonhuman primates

The common marmoset as a translational model of age-related osteoarthritis

The Molecular Pathogenesis of Collagen-Induced Arthritis in Mice—a Model for Rheumatoid Arthritis

MHC-DRB alleles with amino acids Val11, Phe13, and the shared epitopes promote collagen-induced arthritis and a rapid IgG1 response in Filipino cynomolgus macaques

Systemic AA Amyloidosis in the Common Marmoset

Joint Degradation in a Monkey Model of Collagen-Induced Arthritis: Role of Cathepsin K Based on Biochemical Markers and Histological Evaluation.

Marmosets as models of infectious diseases

Cartilage Oligomeric Matrix Protein Induced Arthritis—A New Model for Rheumatoid Arthritis in the C57BL/6 Mouse

Collagen Induced Arthritis: an Experimental Model for Rheumatoid Arthritis with Involvement of Both DTH and Immune Complex Mediated Mechanisms.

Immunotherapeutic potential of collagen V oral administration in mBSA/CFA-induced arthritis

Type Ii Collagen Antibody Response is Enriched in the Synovial Fluid of Rheumatoid Joints and Directed to the Same Major Epitopes As in Collagen Induced Arthritis in Primates and Mice

Efficient Promotion of Collagen Antibody Induced Arthritis (CAIA) Using Four Monoclonal Antibodies Specific for the Major Epitopes Recognized in Both Collagen Induced Arthritis and Rheumatoid Arthritis

The establishment of a rheumatoid arthritis primate model in Macaca fascicularis

Collagen Type II-specific Monoclonal Antibody-Induced Arthritis in Mice: Description of the Disease and the Influence of Age, Sex, and Genes.

Closing the Gap Between Preclinical Biologic Development and Clinical Application in Rheumatoid Arthritis

The Systemic Immune Response to Collagen-Induced Arthritis and the Impact of Bone Injury in Inflammatory Conditions

Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model.

Immunization of rats with homologous type XI collagen leads to chronic and relapsing arthritis with different genetics and joint pathology than arthritis induced with homologous type II collagen.